secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kairos Pharma, LTD. (KAPA)
CIK:        0001962011
Form:       8-K
Filed at:   2026-09-14T20:00:42+00:00
Accession:  0001493152-26-042569
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kairos Pharma issues investor presentation; CEO to present at H.C. Wainwright conference
--------------------------------------------------------------------------------

- Chief Executive Officer John Yu to present at H.C. Wainwright 28th Annual Global Investment Conference in New York, Sept 14-16, 2026.
- Presentation provides update on clinical program and activities; published on company website.
- No financial, clinical, or guidance figures disclosed in the 8-K filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/0001493152-26-042569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer